Skip to content Skip to navigation

Contaminated Drugs

Boxes of Zantac on Shelf

If too many samples of a certain drug are found to be contaminated, shouldn’t sales of the drug be suspended until the contamination problem has been resolved? The complaint for this class action alleges that Sanofi-Aventis US, LLC, Sanofi US Services, Inc. and Chattem, Inc. have faield to pull their drug Zantac off the market, even though it is a brand-name version of the contaminated drug.

Box of Zantac

This complaint concerns a drug brand-named Zantac, and names as defendants maker Sanofi US, LLC, distributor Chattem, Inc., and sellers CVS Health Co. (formerly CVS Caremark) and Dollar Tree Stores, Inc. The complaint alleges that the drug contains “dangerously high levels or N-nitrosodimethylamine (NDMA).

Two Pills on Counter with Prescription Bottles Behind

When the patents for drugs expires, competitor companies may create biosimilars or generics. Biosimilars and generics are supposed to be the equal of brand-name drugs. The FDA says, “All generic drugs approved by FDA have the same high quality, strength, purity, and stability as brand-name drugs.” However, the complaint for this class action alleges that Torrent Pharma, Inc. sold contaminated generics to consumers. The medication at issue is losartan and combinations containing losartan. 

Aurobindo Drug Facility

A number of cases have already been brought on the same allegations as this one: that lots of a drug called valsartan were sold in the US despite being contaminated with a substance called NDEA. The complaint in this case brings suit against Aurobindo Pharma USA, Inc. and Aurobindo Pharma Ltd., a maker of the drug located in India. 

Word "Recall" in Foreground with Hospital Hallway in Background

Valsartan is used to treat high blood pressure and congestive heart failure. A number of drug makers offer generic versions of the drug, but the complaint for this class action alleges that some recent lots have been contaminated. It brings suit against Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Major Pharmaceuticals, Zhejiang Huahai Pharmaceuticals, Ltd. (ZHP), Huahai U.S., Inc., and Rite Aid Corporation.

Package for Mylan Valsartan

When American companies make generic prescription drugs, they may use active pharmaceutical ingredients (APIs) manufactured overseas, where standards may be lower. The complaint for this class action alleges that Mylan Pharmaceuticals, Mylan NV, and Rite Aid Corporation sold medicines containing valsartan contaminated with N-nitrosodiethylamine (NDEA).

Package of Irbesartan from Westminster

Federal law requires that drug manufacturers follow “current Good Manufacturing Practices” (cGMPs) in making their pharmaceuticals. Nevertheless, the complaint for this class action claims that a company in India sold an active pharmaceutical ingredient that was adulterated with a probably carcinogen, and that the ingredient found its way through two American companies to the pharmacy at Walmart. 

Elderly Eye

When you go for an eye treatment for worsening vision, you don’t expect the treatment to leave you blind in that eye. Yet for once the drug used for treatment doesn’t seem to be at fault, and we’re currently investigating what the problem might be.